ALS LIMITED — Capital/Financing Update 2025

Jun 1, 2025

asx release

==> picture [51 x 55] intentionally omitted <==

2 June 2025

Institutional Placement

Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth)

This notice is given by ALS Limited (ACN 009 657 489)(ASX:ALQ) ( ALS ) under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ).

Today ALS has issued 20,958,084 fully paid ordinary shares in ALS to institutional investors ( New Shares ) at an issue price of A$16.70 per New Share.

ALS confirms that:

1. The New Shares were issued without disclosure under Part 6D.2 of the Corporations Act.

2. This notice is being given under section 708A(5)(e) of the Corporations Act.

3. As at the date of this notice, ALS has complied with:

   • a. the provisions of Chapter 2M of the Corporations Act as they apply to ALS; and

   • b. sections 674 and 674A of the Corporations Act

4. As at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act that is required to be set out in this notice.

ENDS

Authorised for release by the Board of Directors.

For further information please contact:

Michael Williams Investor Relations Media enquiries Group Treasurer, Investor Relations & investor@alsglobal.com media@alsglobal.com Business Integration Director ALS Limited ALS Limited michael.williams@alsglobal.com M: + 61 409 001 308

About ALS Limited (ASX: ALQ)

ALS is a global leader in testing, providing comprehensive testing solutions to clients in a wide range of industries around the world. Using state-of-the-art technologies and innovative methodologies, our dedicated international teams deliver the highest-quality testing services and personalised solutions supported by local expertise. We help our clients leverage the power of data-driven insights for a safer and healthier world.

1

alsglobal.com